Koning Corporation news
NORCROSS, Ga., Feb. 1, 2022 /PRNewswire/ -- Koning, a growing medical device startup company based outside Atlanta, had a successful conclusion to 2021. The company recently finished their first Republic crowdfunding campaign, exceeding capital targets, and raising over $2.6M in only 5 months. Koning`s FDA breast screening trial is also underway with participating clinics in Daytona Beach, FL&n
DAYTONA BEACH, Fla., Nov. 1, 2021 /PRNewswire/ -- Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional breast imaging device. The company received FDA PMA approval for commercial, diagnostic use in 2017. Since then, the Koning Breast CT (KBCT) has been installed in clinics and universities in the US and globally.
"This FDA screening trial is a major milestone for radiologists and patients," says Koning P
HONG KONG, Oct. 8, 2021 /PRNewswire/ -- Koning Corporation has been working to get more Koning Breast CT (KBCT) into clinics not only throughout the US, but also around the world. Within the past week, the company has entered into a partnership with Chesa Industries LTD with the intention of putting ten KBCT into clinics across Southeast Asia.
“This partnership will allow many more women to get true 3D breast imaging exams, and without
Atlanta, GA: A month into Koning’s Republic fundraising campaign, the company has already passed a quarter of a million dollars of investments from 740 investors.
“We’re proud of the progress we’ve made on the campaign so far and we’re confident that this positive trajectory will continue”, says Koning’s US CEO, Lutao Ning.
“It goes to show how excited people are about our mission and demonstrates p
Boston, MA: Koning has been selected as a finalist to present at the Women’s Health Innovation Summit on September 14, 2021. Of over 100 applicants, Koning is one of only ten companies that has been chosen and will showcase the Koning Breast CT - a technology that will change millions of women’s lives around the world through no compression, low dose, and true 3D imaging.
“It’s an honor to be selected to present at t